Alzheimer's Drug Response Predicted by Mini-Brains | Health and Fitness News

Health News Today | 2 Min News | The Daily News Now! · Jul 22, 2026 · 2m

Scientists are pioneering a revolutionary approach to Alzheimer’s treatment by using patient-derived brain organoids to predict how individuals will respond to medications for anxiety and agitation. These tiny, lab-grown brain models, made from reprogrammed blood cells, reveal molecular differences tied to Alzheimer’s—and surprisingly, some react positively to antidepressants while others don’t. Even more promising, the extracellular vesicles released by these organoids may act as biomarkers, offering a potential “liquid biopsy” to diagnose Alzheimer’s and personalize treatment. Though early…